These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22131109)

  • 1. Embryotoxicity assessment of developmental neurotoxicants using a neuronal endpoint in the embryonic stem cell test.
    Baek DH; Kim TG; Lim HK; Kang JW; Seong SK; Choi SE; Lim SY; Park SH; Nam BH; Kim EH; Kim MS; Park KL
    J Appl Toxicol; 2012 Aug; 32(8):617-26. PubMed ID: 22131109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
    Stummann TC; Hareng L; Bremer S
    Toxicology; 2007 Dec; 242(1-3):130-43. PubMed ID: 17980949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
    Festag M; Viertel B; Steinberg P; Sehner C
    Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryotoxicity hazard assessment of cadmium and arsenic compounds using embryonic stem cells.
    Stummann TC; Hareng L; Bremer S
    Toxicology; 2008 Oct; 252(1-3):118-22. PubMed ID: 18775467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferability of a modified embryonic stem cell test using a new endpoint for developmental neurotoxicity.
    Baek DH; An SY; Park JH; Choi Y; Park KD; Kang JW; Choi KS; Park SH; Whang MY; Han J; Kim JH; Kim HS; Geum D; Yoo TM
    Toxicol Mech Methods; 2012 Feb; 22(2):118-30. PubMed ID: 22082211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test.
    Peters AK; Steemans M; Hansen E; Mesens N; Verheyen GR; Vanparys P
    Toxicol Sci; 2008 Oct; 105(2):342-50. PubMed ID: 18593728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryotoxicity of lead (II) acetate and aroclor 1254 using a new end point of the embryonic stem cell test.
    Baek DH; Park SH; Park JH; Choi Y; Park KD; Kang JW; Choi KS; Kim HS
    Int J Toxicol; 2011 Oct; 30(5):498-509. PubMed ID: 22013134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular multiple endpoint embryonic stem cell test--a possible approach to test for the teratogenic potential of compounds.
    zur Nieden NI; Kempka G; Ahr HJ
    Toxicol Appl Pharmacol; 2004 Feb; 194(3):257-69. PubMed ID: 14761682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro.
    Buesen R; Genschow E; Slawik B; Visan A; Spielmann H; Luch A; Seiler A
    Toxicol Sci; 2009 Apr; 108(2):389-400. PubMed ID: 19168572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing.
    Hettwer M; Reis-Fernandes MA; Iken M; Ott M; Steinberg P; Nau H
    Reprod Toxicol; 2010 Aug; 30(1):113-20. PubMed ID: 20132877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol.
    van Dartel DA; Zeijen NJ; de la Fonteyne LJ; van Schooten FJ; Piersma AH
    Reprod Toxicol; 2009 Sep; 28(2):254-61. PubMed ID: 19442486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test.
    Seiler A; Visan A; Buesen R; Genschow E; Spielmann H
    Reprod Toxicol; 2004; 18(2):231-40. PubMed ID: 15019721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
    Kuske B; Pulyanina PY; zur Nieden NI
    Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of the embryonic stem cell test endpoint analysis by use of field potential detection.
    Koseki N; Deguchi J; Yamada T; Funabashi H; Seki T
    J Toxicol Sci; 2010 Oct; 35(5):619-29. PubMed ID: 20930457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro.
    Suzuki N; Ando S; Yamashita N; Horie N; Saito K
    Toxicol Sci; 2011 Dec; 124(2):460-71. PubMed ID: 21964422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach.
    Hogberg HT; Kinsner-Ovaskainen A; Coecke S; Hartung T; Bal-Price AK
    Toxicol Sci; 2010 Jan; 113(1):95-115. PubMed ID: 19651682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
    de Jong E; Doedée AM; Reis-Fernandes MA; Nau H; Piersma AH
    Reprod Toxicol; 2011 May; 31(4):375-82. PubMed ID: 21115111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of developmental toxicant identification using gene expression profiling in embryonic stem cell differentiation cultures.
    van Dartel DA; Pennings JL; de la Fonteyne LJ; Brauers KJ; Claessen S; van Delft JH; Kleinjans JC; Piersma AH
    Toxicol Sci; 2011 Jan; 119(1):126-34. PubMed ID: 20935163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in improving the embryonic stem cell test (EST): an overview.
    Buesen R; Visan A; Genschow E; Slawik B; Spielmann H; Seiler A
    ALTEX; 2004; 21(1):15-22. PubMed ID: 14976585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry.
    Paquette JA; Kumpf SW; Streck RD; Thomson JJ; Chapin RE; Stedman DB
    Birth Defects Res B Dev Reprod Toxicol; 2008 Apr; 83(2):104-11. PubMed ID: 18361453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.